On June 6, 2017, DevicePharm was honored to make the opening presentation at the 2017 Spring BioBash in Austin, Texas. The presentation was titled, “So You’re Going To Launch”. It was presented to provide a guide for med-tech executives, marketers, and entrepreneurs who are launching new products, companies, and markets.
Category Archives: Medical Marketing
The scenario is common. A new medical technology is introduced that potentially improves care and practice economics, but also disrupts conventional care patterns. The question in these scenarios is, “How do we quantify the clinical and economic value and how do we communicate that to clinicians?”
DevicePharm co-sponsored, along with Medical Alley Association, an interactive panel titled “Medical Device Marketing Through the Eyes of Your Customers”. The event, held on November 10 at the new U.S. Bank Stadium in Minneapolis, was hosted by DevicePharm CEO, Clay Wilemon, and was an overwhelming success.
DevicePharm, along with six other Orange County professional services firms, co-sponsored the 2016 OCTANe LaunchPad ‘Company Of The Year’ award. The LaunchPad Program gave nine early-stage companies the opportunity to present to a panel of investors with the chance to receive a bundle of professional services ranging from brand development to intellectual property, reimbursement, and financial services.
Big Data. The term is ubiquitous in our culture and its importance was validated by the attendance of over 500 people at the leadoff panel during the OCTANe 2016 Medical Device and Investor Forum. The panel, titled “Using Big Data To Improve Patient Outcomes and Reimbursement” was hosted by DevicePharm CEO, Clay Wilemon.
UK Trade & Investment — the business development arm of the British Consulate — invited DevicePharm CEO & Chief Strategy Officer, Clay Wilemon, to present to UK medical firms during a February conference.
Any marketer that has conducted a direct-to-consumer (DTC) campaign understands the challenge of consumer engagement, especially web engagement. How do you meaningfully engage with interested visitors who are browsing your website in a world of 24/7 communication expectations?
Healthcare reform is changing the way that healthcare marketers think about everything from clinical trials to product launches. New payment models, new delivery models, and HEOR mandates are all creating major changes in marketing focus for medical device, biotech, pharmaceutical, and medical diagnostics companies.
At the 2015 San Antonio Breast Cancer Symposium, Provista introduced Videssa® Breast, a breakthrough that accurately detects the presence or absence of breast cancer with a protein-based blood test. Videssa® Breast provides clinicians, and their patients, with clinical confidence, clarity and peace-of-mind about what to do next when mammography is unclear – detecting the absence or presence of breast cancer by identifying early warning signals called biomarkers.
Millions of Americans have considered weight loss surgery but made the decision that although they wanted significant weight loss, surgery was too big of a step for them. Now, with the U.S. FDA’s approval of the ReShape™ Integrated Dual Balloon System, a non-surgical weight loss procedure is available in the United States. It is called theReShape Procedure and is indicated for people with a BMI of 30 to 40.